CymaBay Therapeutics, Inc.

VICTORY CAPITAL MANAGEMENT INC

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/5/2024

Shares

689,603

Value ($000)

16,288

Weight

0.0%

2019 Q4 - 2023 Q4 (12 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/5/2024	16,288	0.0%	689,603	12/31/2023
2023 Q3	11/6/2023	15,468	0.0%	1,037,433	9/30/2023
2023 Q2	7/27/2023	534	0.0%	48,750	6/30/2023
2023 Q1	5/2/2023	88	0.0%	10,077	3/31/2023
2021 Q3	11/2/2021	155	0.0%	42,448	9/30/2021
2021 Q2	8/3/2021	185	0.0%	42,448	6/30/2021
2021 Q1	5/4/2021	320	0.0%	70,442	3/31/2021
2020 Q4	2/1/2021	420	0.0%	73,215	12/31/2020
2020 Q3	11/9/2020	366	0.0%	50,554	9/30/2020
2020 Q2	8/7/2020	254	0.0%	72,812	6/30/2020
2020 Q1	5/4/2020	108	0.0%	72,812	3/31/2020
2019 Q4	2/6/2020	151	0.0%	76,978	12/31/2019